Loading...
 
Back to the list
Mediterr J Rheumatol 2020;31(Suppl 2):288-94
Article Links
Nocebo-Prone Behaviour in Patients with Autoimmune Rheumatic Diseases during the COVID-19 Pandemic
George E. Fragoulis1, Gerasimos Evangelatos1, Aikaterini Arida1, Vasiliki-Kalliopi Bournia1, Kalliopi Fragiadaki1, Anastasios Karamanakos1, Evrydiki Kravvariti1, Katerina Laskari1, Stylianos Panopoulos1, Maria Pappa1, Dimos D. Mitsikostas2, Maria G. Tektonidou1, Petros P. Sfikakis1
Authors Information

1. First Department of Propaedeutic Internal Medicine, Joint Rheumatology Program, National and Kapodistrian University of Athens Medical School, “Laiko” General Hospital, Athens, Greece

2. First Neurology Department, Aeginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece


George E. Fragoulis,Gerasimos Evangelatos, Vasiliki-Kalliopi Bournia, Kalliopi Fragiadaki, Katerina Laskari, 
Stylianos Panopoulos, Dimos D. Mitsikostas, Maria G. Tektonidou

Keywords: COVID-19, Nocebo, autoimmune rheumatic diseases
References
  1. Pfefferbaum B, North CS. Mental Health and the Covid-19 Pandemic. N Engl J Med 2020 Apr 13.
  2. Kravvariti E, Kitas GD, Mitsikostas DD, Sfikakis PP. Nocebos in rheumatology: emerging concepts and their implications for clinical practice. Nat Rev Rheumatol 2018;14:727-40.
  3. Tracey I. Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans. Nat Med 2010;16:1277-83.
  4. Pouillon L, Socha M, Demore B, Thilly N, Abitbol V, Danese S, et al. The nocebo effect: a clinical challenge in the era of biosimilars. Expert Rev Clin Immunol 2018;14:739-49.
  5. Smolen JS, Goncalves J, Quinn M, Benedetti F, Lee JY. Era of biosimilars in rheumatology: reshaping the healthcare environment. RMD Open 2019;5:e000900.
  6. Kravvariti E, Kitas GD, Sfikakis PP. The Role of the Nocebo Effect in the Use of Biosimilars in Routine Rheumatology Clinical Practice. Mediterr J Rheumatol 2019;30:63-8.
  7. Mitsikostas DD, Deligianni CI. Q-No: a questionnaire to predict nocebo in outpatients seeking neurological consultation. Neurol Sci 2015;36:379-81.
  8. Scherlinger M, Langlois E, Germain V, Schaeverbeke T. Acceptance rate and sociological factors involved in the switch from originator to biosimilar etanercept (SB4). Semin Arthritis Rheum 2019;48:927-32.
  9. Fragoulis GE, Evangelatos G, Arida A, Bournia VK, Fragiadaki K, Karamanakos A, et al. Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic. Ann Rheum Dis 2020 Published Online First: 31 May 2020.
  10. Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, et al. Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China. Int J Environ Res Public Health 2020;17.
  11. Michaud K, Wipfler K, Shaw Y, Simon TA, Cornish A, England BR, et al. Experiences of Patients With Rheumatic Diseases in the United States During Early Days of the COVID-19 Pandemic. ACR Open Rheumatol 2020.
  12. de la Cruz M, Hui D, Parsons HA, Bruera E. Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer. Cancer 2010;116:766-74.
  13. Hofman M, Morrow GR, Roscoe JA, Hickok JT, Mustian KM, Moore DF, et al. Cancer patients' expectations of experiencing treatment-related side effects: a University of Rochester Cancer Center--Community Clinical Oncology Program study of 938 patients from community practices. Cancer 2004;101:851-7.
  14. Bavbek S, Aydın Ö, Sözener ZÇ, Yüksel S. Determinants of nocebo effect during oral drug provocation tests. Allergologia et Immunopathologia 2015;43:339-45.
  15. Qiu J, Shen B, Zhao M, Wang Z, Xie B, Xu Y. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations. Gen Psychiatr 2020;33:e100213.
  16. Geers AL, Helfer SG, Kosbab K, Weiland PE, Landry SJ. Reconsidering the role of personality in placebo effects: dispositional optimism, situational expectations, and the placebo response. J Psychosom Res 2005;58:121-7.
  17. Kern A, Kramm C, Witt CM, Barth J. The influence of personality traits on the placebo/nocebo response: A systematic review. J Psychosom Res 2020;128:109866.